Novartis

Only 26% of breast cancer patients receive information about the risk of their cancer returning. It’s important for patients to understand their risk of recurrence and the importance of continuing therapy.

Mind The Gap supports healthcare professionals by providing topics and communication tips to help ensure patients are properly informed about their recurrence risk.